Management of advanced prostate cancer

被引:6
|
作者
Kaliks, Rafael A.
Del Giglio, Auro
机构
[1] Hematology and Oncology Center for Studies and Research, ABC School of Medicine, SP
[2] Santo André - SP 09060-650
来源
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2008年 / 54卷 / 02期
关键词
prostatic neoplasms/therapy; hormones/therapeutic use; hormonal antineoplastic agents; drug therapy; epidemiology;
D O I
10.1590/S0104-42302008000200025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Geriatricians and general practitioners often follow patients with metastatic prostate cancer, The epidemiology and basic treatment principles of metastatic prostate cancer are discussed aiming to update the topic for the non-oncologist. Hormone manipulation remains the basis of treatment, usually up to a second line of therapy. Selected cases are treated successfully with intermittent androgen ablation, When new hormone-independent clones arise, chemotherapy should be added to therapy that confers improved survival as well as better quality of life when based on taxanes. In specific situations, additional measures such as bisphosphonates and radiation therapy should be included in the treatment. As a rule, the public health system makes available the necessary medication to ensure treatment for the vast majority of patients in Brazil.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 50 条
  • [21] Symptom management in a patient with advanced prostate cancer
    Blacharska-Krzanowska, Katarzyna
    Strzepek, Katarzyna
    Cieslikowski, Damian
    Kozlowski, Michael
    MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2018, 10 (03): : 150 - 156
  • [22] Novel breakthroughs in advanced prostate cancer management
    Lilly, Eddy
    Sarkis, Julien
    Mahmoud, Omar
    El Gharib, Khalil
    Sarkis, Pierre
    Nemr, Elie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 369 - 373
  • [23] Recent Developments in the Management of Advanced Prostate Cancer
    Srinivas, Sandy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 969 - 972
  • [24] Antiandrogen monotherapy in the management of advanced prostate cancer
    Kaisary, AV
    EUROPEAN UROLOGY, 1997, 31 : 14 - 19
  • [25] Management of Advanced Prostate Cancer – Role of the Urologist
    Neal Shore
    Current Urology Reports, 2014, 15
  • [26] Recent progress in management of advanced prostate cancer
    Kantoff, P
    ONCOLOGY-NEW YORK, 2005, 19 (05): : 631 - 636
  • [27] Pain management in patients with advanced prostate cancer
    Olson, KB
    Pienta, KJ
    ONCOLOGY-NEW YORK, 1999, 13 (11): : 1537 - +
  • [28] Management of advanced prostate cancer - new drugs
    Ullen, Anders
    Shah, Carl-Henrik
    Kirkali, Ziya
    ACTA ONCOLOGICA, 2011, 50 : 137 - 140
  • [29] Management of Advanced Prostate Cancer - Role of the Urologist
    Shore, Neal
    CURRENT UROLOGY REPORTS, 2014, 15 (07)
  • [30] Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
    Gillessen, Silke
    Attard, Gerhardt
    Beer, Tomasz M.
    Beltran, Himisha
    Bossi, Alberto
    Bristow, Rob
    Carver, Brett
    Castellano, Daniel
    Chung, Byung Ha
    Clarke, Noel
    Daugaard, Gedske
    Davis, Ian D.
    de Bono, Johann
    dos Reis, Rodolfo Borges
    Drake, Charles G.
    Eeles, Ros
    Efstathiou, Eleni
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix
    Fizazi, Karim
    Frydenberg, Mark
    Gleave, Martin
    Halabi, Susan
    Heidenreich, Axel
    Higano, Celestia S.
    James, Nicolas
    Kantoff, Philip
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Khauli, Raja B.
    Kramer, Gero
    Logothetis, Chris
    Maluf, Fernando
    Morgans, Alicia K.
    Morris, Michael J.
    Mottet, Nicolas
    Murthy, Vedang
    Oh, William
    Ost, Piet
    Padhani, Anwar R.
    Parker, Chris
    Pritchard, Colin C.
    Roach, Mack
    Rubin, Mark A.
    Ryan, Charles
    Saad, Fred
    Sartor, Oliver
    Scher, Howard
    Sella, Avishay
    Shore, Neal
    EUROPEAN UROLOGY, 2018, 73 (02) : 178 - 211